Paradice Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,257,824
Closed -$15.4M 31
2025
Q2
$15.4M Sell
1,257,824
-28,209
-2% -$355K 3.13% 16
2025
Q1
$18.4M Sell
1,286,033
-7,165
-0.6% -$112K 4.12% 13
2024
Q4
$20.6M Buy
1,293,198
+30,949
+2% +$613K 4.08% 14
2024
Q3
$30.3M Sell
1,262,249
-82,700
-6% -$1.89M 5.28% 8
2024
Q2
$26.8M Buy
1,344,949
+69,389
+5% +$1.35M 4.74% 8
2024
Q1
$25.4M Sell
1,275,560
-377,752
-23% -$7.3M 4.41% 10
2023
Q4
$37.1M Sell
1,653,312
-619,446
-27% -$12.8M 4.66% 7
2023
Q3
$46M Buy
2,272,758
+28,323
+1% +$642K 3.94% 10
2023
Q2
$57.4M Sell
2,244,435
-47,873
-2% -$1.26M 4.27% 7
2023
Q1
$68.2M Sell
2,292,308
-50,924
-2% -$1.48M 5.19% 4
2022
Q4
$63.4M Hold
2,343,232
4.91% 5
2022
Q3
$51M Buy
2,343,232
+32,960
+1% +$861K 4.35% 7
2022
Q2
$63.2M Sell
2,310,272
-150,095
-6% -$4.31M 4.83% 3
2022
Q1
$82.4M Sell
2,460,367
-698,048
-22% -$22.5M 4.82% 3
2021
Q4
$110M Buy
3,158,415
+71,186
+2% +$2.3M 4.8% 3
2021
Q3
$96.3M Buy
3,087,229
+645,316
+26% +$21.9M 4.36% 9
2021
Q2
$88.8M Sell
2,441,913
-24,381
-1% -$1.01M 4.12% 10
2021
Q1
$108M Sell
2,466,294
-16,449
-0.7% -$772K 5.18% 3
2020
Q4
$114M Sell
2,482,743
-34,729
-1% -$1.45M 6.4% 2
2020
Q3
$83.6M Sell
2,517,472
-131,655
-5% -$4.21M 6.06% 4
2020
Q2
$77.9M Buy
2,649,127
+70,665
+3% +$2.05M 5.86% 4
2020
Q1
$69.4M Buy
2,578,462
+352,695
+16% +$10.5M 6.77% 3
2019
Q4
$75M Sell
2,225,767
-22,341
-1% -$809K 5.22% 5
2019
Q3
$84.2M Buy
2,248,108
+256,525
+13% +$9.79M 6.24% 4
2019
Q2
$86.9M Buy
1,991,583
+301,082
+18% +$12.9M 6.59% 3
2019
Q1
$72.2M Buy
1,690,501
+197,906
+13% +$8.86M 5.5% 5
2018
Q4
$66.9M Buy
1,492,595
+812,659
+120% +$42.6M 5.72% 4
2018
Q3
$46.6M Sell
679,936
-783,589
-54% -$50.4M 3.21% 16
2018
Q2
$83.8M Sell
1,463,525
-86,120
-6% -$4.55M 5.67% 4
2018
Q1
$71.4M Buy
1,549,645
+32,862
+2% +$1.56M 5.17% 8
2017
Q4
$70M Sell
1,516,783
-48,030
-3% -$2.21M 5.13% 6
2017
Q3
$70.5M Buy
1,564,813
+31,832
+2% +$1.36M 5.28% 5
2017
Q2
$60.2M Buy
1,532,981
+83,000
+6% +$3.14M 4.78% 8
2017
Q1
$55.2M Sell
1,449,981
-2,321
-0.2% -$90.4K 4.6% 8
2016
Q4
$53.7M Buy
1,452,302
+185,256
+15% +$6.62M 5.1% 6
2016
Q3
$43.9M Sell
1,267,046
-90,191
-7% -$3.16M 4.99% 5
2016
Q2
$44.1M Buy
1,357,237
+147,566
+12% +$4.52M 5.28% 6
2016
Q1
$34.8M Buy
1,209,671
+152,662
+14% +$4.07M 4.64% 9
2015
Q4
$35.3M Buy
1,057,009
+392,370
+59% +$12.2M 5.05% 8
2015
Q3
$18.9M Buy
664,639
+215,845
+48% +$7.53M 3.45% 12
2015
Q2
$18.2M Buy
448,794
+95,087
+27% +$4.27M 3.05% 15
2015
Q1
$17.4M Buy
+353,707
New +$16.4M 3.65% 14

Other funds holding AVNS